'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma.
Amber RathorPrabhat Singh MalikPranay TanwarSachin KhuranaHemavathi BaskaraneDeepam PushpamAruna NambirajanDeepali JainPublished in: Journal of cancer research and clinical oncology (2024)
Utilizing a 'plasma first' strategy, given its shorter turnaround time, strong positive concordance and comparable outcomes to tissue biopsy, emerges as a highly specific and reliable method for detecting EGFR mutations in advanced-stage NSCLC.